Therefore, physicians can evaluate VUS variant with given risk score 87 patients with pathogenic, 23 with likely pathogenic, 128 VUS, 29 likely benign and 1 benign BRCA1 and BRCA2 gene variants together with 14 other clinical breast cancer risk factors. This evidence concerns the gene BRCA1 and breast cancer.